Hollow Labs Korea · Est. 2025 · Delaware / Seoul

Independent research
architecture for hard
federal problems.

We identify high-value intersections across biomedical, defense, and technology domains — then build the scientific and contractual infrastructure to pursue them.

5/10 BARDA TechWatch meetings secured

SAM Registered · UEI SDPWJ7B9K8N9

2 Active agency collaborations

What We Do

Research architecture, not just research.

Hollow Labs operates at the boundary between scientific concept and federal funding reality. We develop structured research frameworks — with defined hypotheses, testable modules, and clear STTR/SBIR pathways — then build the institutional partnerships needed to execute them.

Our model is lean and targeted: identify where agency priorities intersect with underexplored science, design a credible entry point, and move fast. We don't wait for the infrastructure to exist — we build it.

Hollow Labs Korea is the operational entity for international research collaboration, registered in both Delaware (Hollow Labs LLC) and Korea. SAM.gov registered with active NCAGE code (544QF) and BARDA BDR number.

Active Projects

Current research portfolio.

Radiation Injury · BARDA

SOBI

Vascular stabilization framework for acute radiation syndrome. Targeting endothelial glycocalyx degradation markers as early diagnostic and therapeutic endpoints. Active BARDA TechWatch engagement with BDR number on file.

Active · Agency engagement ongoing

Neurodegeneration · NINDS STTR

NeuroSentinel

Peripheral intervention framework for early Parkinson's disease. Targeting the enteroendocrine cell–vagal neuron interface to modulate α-synuclein propagation before CNS involvement. STTR collaboration concept in development.

In development · PI outreach

ME/CFS · Frontiers in Systems Neuroscience

Emergency-State Framework

Systems-level framework for persistent immune activation as a driver of ME/CFS pathophysiology. Submitted as sole author; currently under independent peer review.

Peer review · Frontiers

Track Record

What we've built, fast.

2025 Q4 Hollow Labs LLC incorporated in Delaware; 100+ project concepts scoped across biomedical and defense domains Corporate

2025 Q4 5 of 10 BARDA TechWatch outreach meetings secured — 50% response rate on cold agency contact BARDA

2025 Q4 16 proposals submitted to PEO Soldier across defense technology categories DoD

2026 Q1 Hollow Labs Korea registered as Korean LLC; NCAGE 544QF issued by NSPA Regulatory

2026 Q1 SAM.gov entity registration completed (UEI: SDPWJ7B9K8N9) — federal contracting eligibility established SAM.gov

2026 Q1 ME/CFS systems framework paper advanced to independent peer review at Frontiers in Systems Neuroscience Publication

Founder

Wonjun Lee

Founder & CEO

Wonjun Lee is an independent research architect based in Seoul, Korea. He founded Hollow Labs to pursue a specific thesis: that the gap between high-value scientific concepts and federal funding is primarily a structural problem, not a scientific one — and that a sufficiently rigorous and fast-moving small entity can close that gap.

Over the past six months, he has built Hollow Labs from scratch — generating over 100 project concepts, securing 5 BARDA TechWatch meetings from 10 cold approaches, establishing active collaborations with U.S. university researchers, and completing full federal registration (SAM.gov, NCAGE) as a non-U.S. entity.

His work spans radiation injury countermeasures (SOBI, in collaboration with University of Maryland), peripheral neurodegeneration intervention (NeuroSentinel, STTR concept for NINDS), and systems-level frameworks for complex chronic illness. He operates across BARDA, DARPA BTO, NINDS, and DoD funding mechanisms.

Contact: wonjun.lee.contact@gmail.com

Independent research architecture for hard federal problems.